Uncategorized

GLP-1s present a major opportunity for organizations to improve clinical outcomes and reduce long-term healthcare costs. However, payers and providers must balance this potential with challenges such as high upfront spend, adherence issues, and determining which patients will benefit most. Read a more in-depth overview of these considerations in our previous blog post. Managing these…

Few pharmaceuticals have surged in popularity as fast as GLP-1s. This growth is well-justified. GLP-1s, a class of medications originally developed for diabetes and now widely used for weight management, are rapidly reshaping clinical care with far-reaching impacts on chronic disease management, weight loss, and cardiovascular health. Despite long-term benefits, the prescribing of GLP-1s must…